BTK inhibitors

Completing steps towards success checkmark on cubes symbolizing progress
Biotech

Roche reports pivotal MS win, but deaths add to safety questions

The discovery that more patients died on fenebrutinib than on the control drug has spurred further analyses by Roche.
Nick Paul Taylor Mar 2, 2026 6:00am
Completing steps towards success checkmark on cubes symbolizing progress

Roche unveils data behind BTK inhibitor's phase 3 MS win

Feb 9, 2026 7:00am
An envelope with rejected mark Vector illustration

FDA shares CRL for Sanofi MS drug mere weeks after rebuff

Jan 6, 2026 4:30am
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

Nurix trims staff as trial for lead BTK degrader kicks off

Nov 21, 2025 5:05am
Image comparing healthy and degraded myelin sheath

Roche reports phase 3 multiple sclerosis wins for BTK inhibitor

Nov 10, 2025 6:26am
Sanofi

Sanofi's troubled MS hopeful tolebrutinib hit by FDA delay

Sep 22, 2025 8:00am